Roche Diagnostics is a leading player in in vitro diagnostics (IVD) – tests performed in a laboratory or at the point-of-care (PoC) on blood and other samples from patients – with a 20% share of the global market. It is also a leader in diabetes management.
This profile focuses on Roche Diagnostics’
The principal activities of the Professional Diagnostics PoC and Diabetes Care businesses are located in Switzerland, the US, Germany and Austria.
In January 2012, Roche began focusing on expanding its coagulation testing product line in North America beyond physicians’ offices and out-patient clinics, with the development of a full line of coagulation analysers for hospitals and reference labs. To achieve this, the company acquired Verum Diagnostica, a Munich, Germany-based company focused on platelet function testing, which is claimed to be the fastest-growing field in the coagulation diagnostics market. The coagulation analyser product line is expected to be introduced in the US and Canada in 2014, subject to regulatory approval and other requirements. Further attempts to expand into North America were made in 2012 with the failed attempt to acquire Illumina Inc, a San Diego, California-based developer of life-science tools and integrated systems for the analysis of genetic variation and function (see Strategic Focus section). Roche believed this acquisition would have secured its position in the sequencing and microarrays market in North America.
In 2011, Roche Diagnostics was responsible for 22.9% of the Roche Group’s revenue.
This company report provides
Key contact information
Introduction to the company and its current activities
Summary of its financial performance
Who are the company’s major competitors?
Key recent events in an “at a glance” format
Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
Table providing in-depth five-year financial analysis
Employee data, including breakdown by company division and geographic location
Investigates the company’s aims and its areas of focus
Core product areas, key brands, product approvals and launches
Research and Development
How much has been invested in R&D?
Where is the research based?
What alliances and agreements does the company have and with whom?
Manufacturing and Distribution
Identifying the company’s manufacturing locations
Sales and marketing facilities
With whom has the company reached agreements and what do they involve?
Key contracts awarded
Mergers, Acquisitions, and Divestments
Key Corporate Events
First Quarter 2012 Financial Results 3
2011 Financial Results 3
Five-Year Financial Data 9
Operational Excellence Programme11
R&D Strategy 12
Recent Key Events 14
Coagulation Monitoring Systems17
Clinical Chemistry/Immunology Testing Solutions17
For more information kindly visit :
Roche Diagnostics Medical Device Company Intelligence Report
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Follow us on twitter: http://twitter.com/#!/